Millennium Management’s Assembly Biosciences ASMB Stock Holding History

Millennium Management’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.48M	Buy	233,650 +135,429	+138%	+$3.86M	﹤0.01%	2642
2025 Q4	$3.34M	Buy	98,221 +76,613	+355%	+$2.47M	﹤0.01%	3441
2025 Q3	$553K	Buy	+21,608	New	+$474K	﹤0.01%	5006
2024 Q4	–	Sell	-37,553	Closed	-$569K	–	5940
2024 Q3	$569K	Sell	37,553 -85,905	-70%	-$1.31M	﹤0.01%	4723
2024 Q2	$1.69M	Sell	123,458 -1,464	-1%	-$20.9K	﹤0.01%	3683
2024 Q1	$1.66M	Buy	124,922 +4,085	+3%	+$47.6K	﹤0.01%	3891
2023 Q4	$1.19M	Buy	120,837 +3,335	+3%	+$31.7K	﹤0.01%	4017
2023 Q3	$1.25M	Sell	117,502 -3,066	-3%	-$36.9K	﹤0.01%	4004
2023 Q2	$1.66M	Sell	120,568 -264	-0.2%	-$3.24K	﹤0.01%	3637
2023 Q1	$1.22M	Sell	120,832 -3,969	-3%	-$67K	﹤0.01%	3910
2022 Q4	$1.95M	Sell	124,801 -4,107	-3%	-$70.2K	﹤0.01%	3594
2022 Q3	$2.54M	Buy	128,908 +10,726	+9%	+$259K	﹤0.01%	3532
2022 Q2	$2.98M	Buy	118,182 +4,430	+4%	+$102K	﹤0.01%	3313
2022 Q1	$2.81M	Buy	113,752 +85,924	+309%	+$1.84M	﹤0.01%	3557
2021 Q4	$778K	Buy	27,828 +4,042	+17%	+$133K	﹤0.01%	4647
2021 Q3	$993K	Sell	23,786 -20,575	-46%	-$862K	﹤0.01%	4695
2021 Q2	$2.06M	Buy	44,361 +37,091	+510%	+$1.84M	﹤0.01%	3919
2021 Q1	$401K	Buy	+7,270	New	+$482K	﹤0.01%	5005
2019 Q4	–	Sell	-933	Closed	-$110K	–	4184
2019 Q3	$110K	Sell	933 -16,709	-95%	-$2.53M	﹤0.01%	3951
2019 Q2	$2.86M	Buy	17,642 +15,030	+575%	+$2.86M	﹤0.01%	2190
2019 Q1	$617K	Buy	+2,612	New	+$661K	﹤0.01%	3140
2018 Q4	–	Sell	-4,387	Closed	-$1.96M	–	3730
2018 Q3	$1.96M	Buy	4,387 +2,282	+108%	+$1.07M	﹤0.01%	2455
2018 Q2	$990K	Sell	2,105 -528	-20%	-$279K	﹤0.01%	2842
2018 Q1	$1.55M	Sell	2,633 -8,506	-76%	-$5.27M	﹤0.01%	2467
2017 Q4	$6.05M	Buy	11,139 +2,600	+30%	+$1.18M	0.01%	1642
2017 Q3	$3.58M	Sell	8,539 -3,600	-30%	-$1.1M	0.01%	1844
2017 Q2	$3.01M	Sell	12,139 -9,005	-43%	-$2.54M	0.01%	1824
2017 Q1	$6.47M	Sell	21,144 -8,848	-30%	-$2.17M	0.01%	1297
2016 Q4	$4.37M	Sell	29,992 -317	-1%	-$47.1K	0.01%	1417
2016 Q3	$2.62M	Sell	30,309 -5,186	-15%	-$401K	﹤0.01%	1765
2016 Q2	$2.36M	Buy	35,495 +7,601	+27%	+$499K	0.01%	1695
2016 Q1	$1.68M	Sell	27,894 -1,578	-5%	-$106K	﹤0.01%	1884
2015 Q4	$2.66M	Sell	29,472 -2,203	-7%	-$240K	0.01%	1753
2015 Q3	$3.63M	Buy	31,675 +4,000	+14%	+$703K	0.01%	1515
2015 Q2	$6.4M	Sell	27,675 -5,808	-17%	-$1.12M	0.01%	1232
2015 Q1	$5.32M	Buy	33,483 +25,272	+308%	+$3.42M	0.01%	1383
2014 Q4	$774K	Buy	8,211 +123	+2%	+$12.1K	﹤0.01%	2676
2014 Q3	$795K	Sell	8,088 -279	-3%	-$24.7K	﹤0.01%	2457
2014 Q2	$658K	Buy	8,367 +8,008	+2,231%	+$568K	﹤0.01%	2429
2014 Q1	$27K	Buy	+359	New	+$55.9K	﹤0.01%	3379

Other funds holding ASMB

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Millennium Management's ASMB Position: Q1 2026 in Review

Millennium Management increased its Assembly Biosciences (ASMB) stake by 138% in Q1 2026, buying an estimated $3.86M and bringing the position to 233,650 shares worth $6.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2642.

Millennium Management first reported a position in ASMB in Q1 2014 and has held it in 40 quarters since. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

Millennium Management held 233,650 shares of Assembly Biosciences worth $6.48M as of Q1 2026.
Millennium Management bought 135,429 Assembly Biosciences shares in Q1 2026, an estimated $3.86M.
Assembly Biosciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2642 holding.
Millennium Management first reported a position in Assembly Biosciences in Q1 2014 and has held it in 40 quarters since.
75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.